Primary Spinal Infections in Patients With Hematologic Immunocompromising Conditions: A Systematic Literature Review

J Am Acad Orthop Surg Glob Res Rev. 2023 May 8;7(5):e22.00178. doi: 10.5435/JAAOSGlobal-D-22-00178. eCollection 2023 May 1.

Abstract

Purpose: Primary spinal infections (PSIs) are a group of infectious diseases characterized by inflammation of the end plate-disk unit or its surroundings. PSI is considered more prevalent and aggressive among patients with chronic immunocompromised states. Association of PSIs, immunocompromising cancers, and hemoglobinopathies has not been systematically analyzed. We conducted a systematic review to study characteristics, clinical presentation, and mortality of patients with PSI in the setting of hematologic disease.

Methods: A systematic literature search in PubMed, Web of Science, and Scopus was conducted in April 2022 in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We included retrospective case series and individual case reports.

Results: On careful review, 28 articles published between 1970 and 2022 were selected. These studies featured 29 patients who met inclusion criteria (mean age 29 years, age range 1.5 to 67 years; 63.3% male). Lumbar infection was the most common location (65.5%), with Salmonella (24.1%) as the main causative microorganism. Neurologic compromise was present in 41% of patients, and surgical intervention occurred in 48.3%. Average antibiotic duration was 13 weeks. The postoperative complication rate was 21.4%, with a mortality of 6.9%.

Conclusion: PSI in patients with hematologic disease, while having shorter periods to diagnosis, presents increased rates of neurologic deficit, surgical intervention, and complications.

Publication types

  • Systematic Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aggression*
  • Anti-Bacterial Agents
  • Bone Plates
  • Child
  • Child, Preschool
  • Female
  • Hemoglobinopathies*
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Retrospective Studies
  • Young Adult

Substances

  • Anti-Bacterial Agents